Arrowhead Pharmaceuticals, Inc. (ARWR)
77.91
-1.14
(-1.44%)
USD |
NASDAQ |
May 29, 16:00
77.89
-0.02
(-0.03%)
After-Hours: 20:00
Arrowhead Pharmaceuticals Total Assets (Quarterly) : 2.268B for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Sarepta Therapeutics, Inc. | 3.179B |
| Revolution Medicines, Inc. | 2.254B |
| Kymera Therapeutics, Inc. | 1.669B |
| ImmunityBio, Inc. | 646.64M |
| Vera Therapeutics, Inc. | 621.74M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.669B |
| Shareholders Equity (Quarterly) | 613.98M |
| Debt to Equity Ratio | 2.237 |
| Current Ratio | 6.232 |
| Net Debt Paydown Yield | -1.14% |